Novoic

Novoic

AI-based early detection of Alzheimer's disease

About Novoic

Simplify's Rating
Why Novoic is rated
B+
Rated C on Competitive Edge
Rated A on Growth Potential
Rated A on Differentiation

Industries

AI & Machine Learning

Healthcare

Company Size

1-10

Company Stage

Seed

Total Funding

$2.6M

Headquarters

London, United Kingdom

Founded

2019

Overview

Novoic focuses on the early detection of Alzheimer's disease using artificial intelligence to analyze speech patterns. Their technology can identify subtle cognitive impairments in a quick, 10-minute process that can be performed anywhere, making it accessible to a wide range of users. The primary clients are medical institutions, with over 50 centers currently using their software, which is designed to be user-friendly and low-burden. Novoic aims to serve underserved communities where access to Alzheimer's detection is limited. Their AI algorithms have been validated through clinical trials and utilize diverse datasets to enhance accuracy and equity. The goal of Novoic is to provide an effective and accessible solution for early Alzheimer's detection, improving healthcare outcomes for individuals at risk.

📈
Significant Headcount Growth
Simplify Jobs

Simplify's Take

What believers are saying

  • Novoic's technology aligns with the growing demand for remote diagnostic tools.
  • The rise of digital biomarkers offers partnership opportunities with pharmaceutical companies.
  • Increased focus on mental health boosts demand for early detection tools like Novoic's.

What critics are saying

  • Emerging competitors in AI-driven speech analysis could capture market share.
  • Rapid AI development may render Novoic's algorithms outdated if not updated.
  • Data privacy concerns could lead to regulatory scrutiny, impacting operations.

What makes Novoic unique

  • Novoic uses AI to detect Alzheimer's through speech analysis, a unique approach.
  • Their software is user-friendly and can be used on any smart device.
  • Novoic's algorithms are validated by clinical trials, ensuring accuracy and reliability.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$2.6M

Below

Industry Average

Funded Over

1 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Below Average

Industry standards

$3.3M
$2M
Netflix
$2.3M
Instacart
$2.6M
Novoic
$3M
Robinhood

Company News

UK Tech News
Jul 31st, 2020
Novoic secures £2 million Seed Investment from Anthemis

Novoic Raises £2 Million Seed Investment for AI-based Speech Analysis to Detect Neurological Diseases Earlier Anthemis Exponential Ventures leads the round, with participation from APEX Ventures and Entrepreneur First LONDON, July 31, 2020 Novoic, a digital biotechnology company developing speech-based AI algorithms for diagnosis and monitoring of health conditions, today announced it has raised £2.0 million in Seed funding […]

PR Newswire
Jul 31st, 2020
Novoic Raises £2 Million Seed Investment for AI-based Speech Analysis to Detect Neurological Diseases Earlier

Novoic, a digital biotechnology company developing speech-based AI algorithms for diagnosis and monitoring of health conditions, today announced it has raised £2.0 million in Seed funding to scale up its AI research team and advance its clinical programmes, including in early-stage Alzheimer's and Parkinson's disease.

There are no jobs for Novoic right now.

Find jobs on Simplify and start your career today

💡
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →